Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-08-08

Clinical Trial Update: Systematic Adjunction of Vasopressine in Septic Shock [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial evaluating the adjunctive use of vasopressin in septic shock; the study is not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • VASOPRESSIN (VASOPRESSIN)

Snippet

Sponsor: Assistance Publique Hopitaux De Marseille | Conditions: Septic Shock | Phase 3 | Status: NOT_YET_RECRUITING